Board welcomes Mayo Clinic Laboratories CEO Dr. William Morice and Clinical Lab 2.0 Founder Khosrow Shotorbani; Second Annual In-Person Advisory Meeting in San Diego Drives Directions for Product Development

Cerberus Ventures leads financing alongside five physician users of Virchow’s biopsy technologies

Two organizations to collaborate in expanding longitudinal evidence-based cancer therapy to more patients

New technology allows testing after biopsies using only tumor cells normally discarded as medical waste –- concept could spare some patients from chemotherapy 

User interface designed for clinical oncologists as well as the targeted therapy research community

LA JOLLA, CA–November 17, 2025 – Corramedical, Inc. announced today that its name has changed to Virchow Medical, signaling a transformative new chapter for the industry leader in biological specimen stewardship.

LA JOLLA, CA, UNITED STATES, June 23, 2025 /EINPresswire.com/ — Corramedical, Inc., a leader in innovative biopsy specimen technologies, is now accepting applications for the 2025 Biopsy Catchment Biobank Investigators Award.

A new publication in the Journal of Clinical Oncology (J Clin Oncol. 2025;43(16):e13898) by Drs. Saloni Walia and Pamela Ward at USC Medical Center describes a novel method to enhance tumor biopsy analysis.

Board Will Accelerate Company’s Mission to Make Precision Medicine Available to More Patients; Thought Leaders in Pathology, Oncology, Radiology, and Genomic Sequencing